PATENT CLAIM ANALYSIS

Application Number: 15980095
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "501000"]

Abstract:
The present disclosure generally relates to nanoparticles having about 0.2 to about 35 weight percent of pemetrexed; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol. Other aspects of the invention include methods of making such nanoparticles.

Claim (Index 2):
The therapeutic nanoparticle of  claim 1  wherein said therapeutic agent is a pemetrexed.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.375
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13903549', '13478691', '12485399', '13862027', '13553210']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8034561000143513
- 35 USC 102 Novelty (BERT): 0.5574746166368354
- Combined Prediction Score: 0.7788579516765997
- Mean Citation Score: 428.190282
- Max Citation Score: 446.59735
- Similarity Product: 342.8484540211618

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test